TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/15/23 17:00 | 6/15/23 | ITRM | Iterum Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Hecht Beth | L2 | D | M.d | 0 | 0.00 | 0 | 16 | 531 | 19 | D | |||||||||||||||
6/24/22 18:00 | 6/23/22 | ITRM | Iterum Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Hecht Beth | L2 | D | M.d | 0 | 0.00 | 0 | 37 | 460 | 45 | D | |||||||||||||||
3/22/22 19:00 | 3/18/22 | ITRM | Iterum Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Hecht Beth | L2 | D | M.d | 0 | 0.00 | 0 | 8 | 999% | 8 | D | |||||||||||||||
3/16/20 16:07 | 3/13/20 | XERS | Xeris Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hecht Beth | IL | O | See Rema | P | 8 | 1.97 | 0 | 4 | 8 | 57 | D | ||||||||||||||
2/18/20 17:02 | 2/14/20 | XERS | Xeris Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hecht Beth | IL | O | See Rema | P | 17 | 4.15 | 0 | 4 | 98 | 8 | D | ||||||||||||||
2/22/19 16:36 | 2/19/19 | XERS | Xeris Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hecht Beth | IL | O | See Rema | P | 25 | 10.00 | 0 | 3 | New | 3 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |